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ABSTRACT
Background Patient safety is vital to well-functioning health systems. A key com-
ponent is safe prescribing, particularly in primary care where most medications 
are prescribed. Previous research has demonstrated that the number of patients 
exposed to potentially hazardous prescribing can be reduced by interrogating the 
electronic health record (EHR) database of general practices and providing feed-
back to general practitioners (GPs) in a pharmacist-led intervention. We aimed to 
develop and roll out an online dashboard application that delivers this audit and 
feedback intervention in a continuous fashion.
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INTRODUCTION
Patient safety has become an integral part of quality manage-
ment in healthcare systems worldwide. While patient safety 
research has traditionally focused on secondary care,1–3 
primary care, as the cornerstone of modern healthcare sys-
tems,4 is increasingly recognised as an area where major 
improvements in patient safety can be achieved,5,6 especially 
due to the large numbers of medications that are prescribed 
on a daily basis.7 It has been shown that one in 20 prescrip-
tions in primary care contain errors, and one in 550 contain 
potentially life threatening errors.7 One in 25 hospital admis-
sions are the result of prescribing errors in primary care,8 and 
adverse drug reactions, of which most are avoidable, cost the 
NHS an estimated £500 million per year.9
The potential for Information Technology (IT) systems 
to improve safety within healthcare is large and well docu-
mented.10,11 For prescribing safety, there are examples 
where IT systems have had positive12 and negative13,14 
effects. IT-based interventions for improving prescribing 
safety fall broadly into two categories: clinical decision sup-
port (CDS) and electronic audit and feedback (eA&F). CDS 
systems, such as pop-up alerts, attempt to influence behav-
iour at the point of care and while some studies have shown 
benefits,15 others have shown that clinicians can suffer from 
‘alert fatigue’ where poorly targeted alerts lead to their routine 
dismissal.16,17 eA&F systems, such as dashboards, provide 
feedback away from the point of care, usually at a population 
level, to allow for clinicians to review, and potentially change, 
their practice retrospectively.18 A systematic review of eA&F 
systems found a wide degree of heterogeneity in both the 
identified studies and their effects.19 Another literature review, 
specifically focusing on dashboards, had similar findings and 
called for more research to be undertaken to help influence 
the design of such systems.20 Despite the widespread usage 
of such dashboards, there exists little evidence as to what 
factors contribute to their success or failure.21
A common limitation of both types of intervention is that 
they often only indicate problems, without necessarily provid-
ing solutions. Even when specific actions are recommended, 
clinicians do not necessarily have the time or skills to act 
appropriately.22 The University of Nottingham, therefore, 
developed the pharmacist-led information technology inter-
vention for reducing medication errors (PINCER) in primary 
care. The PINCER intervention is based on computer-gen-
erated feedback that identifies patients for whom potentially 
hazardous prescribing practices are present, but crucially 
adds educational outreach visits by trained pharmacists23 
to general practices where they work with the local staff to 
resolve any confirmed hazardous prescribing incidents and 
to prevent their reoccurrence. The intervention was shown to 
be more effective at reducing numbers of at-risk patients than 
computer-generated feedback alone24; proving the pharma-
cist visit plays a crucial role in effectively solving prescribing 
errors. It was also shown to be likely (59% chance) cost-
effective in reducing prescription errors.24,25
There are indications that the reduction in risk due to 
PINCER is only temporary because it does not always 
reduce the incident erroneous prescribing behaviour.24 This 
is in part because the PINCER feedback mechanism relies 
on snapshots of data extracted from the electronic health 
record (EHR) database, while feedback is known to be more 
effective when it is provided more than once.26 Therefore, 
we aimed to build upon PINCER in order to create a con-
tinuous feedback loop for cycles of quality improvement. 
Our objectives were to develop an application that identifies 
patients exposed to potentially hazardous prescribing to end 
users and is updated on a daily basis, and roll out the sys-
tem across Salford, UK, where our previous research has 
shown the prevalence of potentially hazardous prescribing 
is greater than 5%.27
Method Based on initial system requirements, we designed the dashboard’s user 
interface over three iterations with six GPs, seven pharmacists and a member of 
the public. Prescribing safety indicators from previous work were implemented in 
the dashboard. Pharmacists were trained to use the intervention and deliver it to 
general practices.
Results A web-based electronic dashboard was developed and linked to shared 
care records in Salford, UK. The completed dashboard was deployed in all but one 
(n = 43) general practices in the region. By November 2017, 36 pharmacists had 
been trained in delivering the intervention to practices. There were 135 registered 
users of the dashboard, with an average of 91 user sessions a week.
Conclusion We have developed and successfully rolled out of a complex, phar-
macist-led dashboard intervention in Salford, UK. System usage statistics indicate 
broad and sustained uptake of the intervention. The use of systems that provide 
regularly updated audit information may be an important contributor towards medi-
cation safety in primary care. 
Keywords: patient safety, drug prescriptions, electronic audit and feedback, 
dashboard
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METHODS
System requirements
Based on an initial scope definition created by a senior clini-
cal pharmacy researcher (Darren M. Ashcroft) and the prin-
cipal investigator of the PINCER study (Anthony J. Avery), it 
was decided that a front-end dashboard application and the 
associated back end was required that would:
1) receive, validate and process data extracts of patient 
records from general practitioner (GP) systems on 
a daily basis, via an existing shared care record 
infrastructure – the Salford Integrated Record (SIR);
2) execute queries to the GP system data, based on 
pre-defined indicators, to identify patients at risk of 
adverse medication events;
3) present lists of at-risk patients to GPs and 
pharmacists, in a secure environment, restricting the 
visibility of patient identifying information to those 
clinicians that are responsible for that patient’s care;
4) provide the results in a timely, user friendly and 
actionable manner.
The indicators to be used in the dashboard were selected 
from the set of 56 prescribing safety indicators for GPs identi-
fied by Spencer et al.28 Indicators were selected based on 
their severity and the practicality of extracting the relevant 
information from clinical records. They aim to prevent: gas-
trointestinal bleeding; asthma exacerbations; acute kidney 
injury; liver damage and neutropenia; hypo and hyperthyroid-
ism and thrombotic risks. The list of indicators in the dash-
board is available in Table 1 in the Supplementary Material. 
Computable representations of the indicators were required 
which would involve creating clinical code sets29 for each 
component, and determining whether a patient was pre-
scribed to take a medication at a given point in time. This last 
requirement is not simple as although prescription events in 
UK primary care are always recorded electronically, there is 
usually no coded record when a medication is stopped, so 
instead the termination of the medication must be inferred by 
the lack of a repeat prescription.
It was also decided that the system’s feedback regarding 
each indicator would consist of a numerator (also known as 
the affected or ‘at-risk’ patients), and a denominator (also 
known as the eligible patients). The ‘affected patients’ are 
those who have breached the conditions of the indicator and 
are therefore those patients at risk from potentially hazardous 
prescribing who need corrective action. The ‘eligible patients’ 
are those who meet a particular subset of the conditions of 
the indicator and are the population of patients against which 
the affected patients can be measured. The terms numera-
tor and denominator are used as the proportion of eligible 
patients who are also affected patients can be used to com-
pare between practices of different sizes and demographics.
Engineering methods
The initial design of the dashboard’s user interface was cre-
ated following an iterative process which was informed by 
short interviews with key stakeholders involving six GPs, 
seven clinical commissioning group (CCG) pharmacists and 
one member of our patient and public involvement group. 
Prototype dashboard designs were reviewed by the stake-
holders during interview and feedback sought. This feedback 
was incorporated into the design for the next dashboard 
iteration.30
The software architecture of the dashboard, the user 
interface and all the associated back-end processes were 
designed by the lead author Richard Williams. The software 
development was undertaken by Richard Williams and Colin 
Davies. Where possible open-source technologies were used 
to ensure that the system could be made publically available 
in the future if required. Operating systems and server archi-
tecture were designed in order to meet the requirements of 
the secure server hosting within the Salford Royal Foundation 
Trust (SRFT) data centre.
System usage monitoring
A final requirement was that the system should track usage, 
and record all interactions with the dashboard down to indi-
vidual mouse clicks, hovers and non-sensitive key strokes, 
that is, not passwords. A large volume of usage tracking data 
will therefore be collected enabling us to report on the fre-
quency and duration with which the dashboard is used, who 
its primary users are (e.g. pharmacists or GPs), and how this 
varies between practices and over time. It will also allow us to 
assess which feedback modalities provided by the dashboard 
(table, benchmark charts, trend charts and patient lists) are 
typically accessed by users, and under which circumstances. 
Finally, we can analyse which areas of medication safety (i.e. 
which indicators) users tend to focus on when they access 
the dashboard.
Implementation and roll-out
Any general practice in Salford was eligible for receiving the 
intervention provided they had access to SIR. Research team 
members met with Salford CCG leads and GP quality leads 
to identify practices for recruitment. Once identified, the CCG 
pharmacy team (supported by the research team) provided 
practice managers/senior partners with an information sheet 
about the intervention for distribution amongst practice staff 
and an invitation to take part.
If practices decided to take part, their staff received online 
access to the dashboard. No physical installation at the prac-
tice level is necessary. In addition, trained NHS clinical phar-
macists will visit the practices regularly for at least 12 weeks, 
access the dashboard, and advise on changes in medication 
prescribing/monitoring in collaboration with practice staff.
Pharmacist time was resourced by Salford CCG and by 
the NIHR Greater Manchester Patient Safety Translational 
Research Centre (http://www.patientsafety.manchester.
ac.uk/). Pharmacists were recruited and trained to help 
deliver the intervention. The training was based on the original 
PINCER trial pharmacist training23 and involved: introducing 
the prescribing safety indicators included in the dashboard 
and the risk they pose to patients; the importance of academic 
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detailing and causation analysis/systems thinking; describ-
ing the SMASH dashboard and clinical pharmacist interven-
tion and developing the understanding of how to respond to 
potentially hazardous prescribing in practice. Each pharma-
cist was assigned to one or more practices with whom they 
arranged an initial meeting during which they talked to the 
practice about the indicators and showed them how to use 
the dashboard. Pharmacists and GPs were encouraged to 
focus on resolving cases of potentially hazardous prescribing 
identified by the dashboard during an initial 12-week ‘inten-
sive’ period. From the date of the initial meeting with each 
general practice, we followed up that practice for 12 months 
to discover: whether the numbers of at risk patients reduce; 
whether any reduction is sustained; how people use the sys-
tem and how their use affects patient outcomes.
RESULTS
Architecture
The system is deployed to two servers (see Figure 1), running 
Windows Server 2012, in the secure data centre of the SRFT. 
One server runs the main patient database using SQL Server 
2012, and the other runs SMASH – the web application that 
the users access. SMASH is rendered on the client side with 
AngularJs,31 and is served with data via a RESTful API run-
ning on NodeJS32 and Express.33 It is available on the secure 
NHS N3 network meaning only people on that network can 
access the dashboard. Firewalls ensure that only recruited 
practices can view the dashboard. Users can access the site 
remotely using a virtual private network (VPN) connection to 
their practice.
Each day at midnight, the system receives data from pri-
mary care EHR data sources. Currently, this is SIR, a data 
warehouse containing all primary care data from Salford, 
though the system allows any suitable primary care data 
source to be incorporated. Once the data is updated, another 
batch runs to execute SQL stored procedures against 
the patient data to generate lists of at-risk patients for the 
front-end web application. These report data are copied to 
MongoDB34 on the web application server. The entire pro-
cess takes about 2 hours.
Indicator development
We have developed computable representations of each 
indicator. Clinical code sets29 were created for each com-
ponent of the indicator. For example, the indicator that 
looks for asthmatic patients who are prescribed a non-
selective beta blocker required two main code sets: one 
code set to identify asthmatic patients and one to identify 
beta blocker prescriptions. In fact, a third set of codes for 
the event ‘asthma resolved’ was required so that patients 
whose asthma is no longer active would not be detected 
by the indicator. 
To determine when a patient was prescribed to take a med-
ication, we used two approaches. The first method was to 
count any patient with a prescription in the previous n months, 
Secure Salford Network














Figure 1 Architecture diagram of SMASH. The EHR data are received and processed on the database server, 
report files are transferred to the web server and presented to the end user via a web interface
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where in our case, and for the current PINCER indicators, 
n = 3 months, but with longer periods for medications, such 
as combined hormonal contraceptives (n = 6 months), which 
often have longer prescriptions. The second approach was 
to reuse an algorithm that we had previously developed that 
considers the date of the prescription, the amount prescribed 
and the rate of medication usage (‘take 2 a day’) to determine 
when the patient has likely stopped the medication without 
the occurrence of another prescription.35
System functionality
For users assigned to a single practice, the first screen 
after logging in presents a summary table for their practice 
on today’s date. For users with multiple practices, the user 
must first select a practice before viewing the summary. A 
second tab presents detailed information for each indicator 
(Figure 2 – all data in this and future screenshots is fictitious). 
The number of affected and eligible patients, the proportion 
of eligible patients affected and the current CCG average can 
be viewed here. A comparison date, defaulting to 30 days 
ago, allows the system to show the user: how many affected 
patients have been resolved; how many remain affected and 
how many new cases there have been since this compari-
son date. The user can: change the date of the report and 
the comparison date; sort the table by each column; select 
certain indicators to always appear on top irrespective of the 
sorting and drill down into lists of patients by clicking on any 
number within the table. A third tab displays this information 
in charts. One example visually compares the user’s prac-
tice with the average across the CCG (Figure 3). Another 
example, not displayed here, shows how the practice’s per-
formance changes over time.
Selecting one of the hyperlinked numbers within the table in 
Figure 2 takes the user to a screen with a list of patients affected 
by the selected indicator on the selected date (Figure 4). For 
each patient, we display: their NHS number, which indicators 
they are breaching, and for how long they have been affected. 
The clinician can look up the patient in the practice’s EHR to 
determine an appropriate course of action. The selected indi-
cator and date of interest can be changed.
From the patient list (Figure 4), the user can select a tab 
named ‘Information’ to display a summary of the evidence 
supporting the selected indicator (Figure 5). This includes: 
the risk to patients; links to the academic literature supply-
ing the evidence; the consequences of inaction and possible 
actions that could be taken.
Finally, some users are given the role of ‘CCG user’ which 
allows them to see summary performance measures across 
all practices within the CCG. They can view the proportion of 
Figure 2 System screenshot: indicator list for a practice. It shows number and proportion of patients affected, 
compares performance with the past, and allows the user to view lists of patients by clicking the hyperlinked 
numbers. CKD = chronic kidney disease; NSAID = nonsteroidal anti-inflammatory drug; GastProt = gastrointestinal 
protective medication; Warf = warfarin; NOAC = novel oral anticoagulant; LABA = long-acting beta-adrenoceptor 
agonist; ICS = inhaled corticosteroid
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at-risk patients in each practice for a single indicator, or for all 
indicators, in table or chart form (Figure 6).
Pharmacist and practice recruitment
By October 2017, 36 pharmacists, three pharmacy technicians 
and two CCG managers were trained to use the dashboard 
and how to introduce it to general practices. Although pharma-
cists and general practices were encouraged to focus on an 
initial 12-week ‘intensive’ period, in many cases, pharmacists 
continued to monitor and use the dashboard after this time.
We recruited 43 out of 44 general practices within Salford. 
The missing practice wanted to be involved but does not con-
tribute to SIR and so was ineligible for the intervention. The 
first practice recruited completed the 12-month follow-up on 
17 April 2017, and the last practice recruited will complete in 
September 2018. Effects on prescribing safety and adverse 
events will be evaluated thereafter in an interrupted time 
series analysis.
Usage
As of 17 November 2017, there are 135 registered users 
(51 pharmacists, 48 GPs and 36 other practice staff such as 
nurses and technicians) in the dashboard, excluding devel-
opers and research team members, with 28 users (all phar-
macists) logging into the system in the last month (since 18 
October 2017). In 2017, there have been an average of 91 
user sessions per week (SD = 39), with an average duration 
of 17 minutes.
Preliminary findings
On 31 January 2017, we conducted an interim analysis com-
paring recruited practices with at least 1 month’s usage, with 
those practices not yet recruited or with less than 1 month’s 
usage. The number of at-risk patients in recruited practices 
(n = 32) had fallen from 1444 on 1 January 2016 to 882 on 
31 January 2017. This is a mean reduction of 17.6 patients 
per practice and is significant (p = 0.0002) when compared 
with the mean reduction of 2.1 patients in practices not yet 
recruited (n = 12).
DISCUSSION
We have developed SMASH, a dashboard for displaying 
patients ‘at-risk’ of a serious adverse event, such as acute 
Figure 3 System screenshot: chart showing the user’s practice’s proportion of affected patients per indicator 
compared with the CCG. GiB = gastrointestinal bleed; PU = peptic ulcer; GP = gastrointestinal protective 
medication; ASP = aspirin; CLOP = clopidogrel; CHC = combined hormonal contraceptive; LOOP = loop diuretic; 
U&E = urea and electrolytes; HF = heart failure; BMI = body mass index; AMIOD = amiodarone; OEST = oestrogen; 
MET = metformin; Mtx = methotrexate
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Figure 4 System screenshot: a list of patients currently flagged by SMASH for the ‘asthma and beta blocker’ indicator. 
It shows the NHS number, which indicators the patient is breaching, and when they first flagged for this indicator
kidney injury or gastrointestinal bleeds, to pharmacists and 
GPs, and deployed it as part of a pharmacist-led interven-
tion within Salford, UK. The system has seen high rates of 
adoption, with usage in all but one practice, and many users 
logging in each week.
Improving medication safety has become a major aim in 
all clinical settings. The potential for IT systems to contrib-
ute to this aim is substantial, but data on the effectiveness of 
IT interventions remains controversial. A systematic review 
of the effects of IT interventions on medication safety in pri-
mary care36 found that pharmacist-led IT interventions were 
successful in reducing medication errors. They suggest that 
the detection of unsafe medication by pharmacists together 
with feedback to and discussion with physicians may be an 
additional safeguard in the complex process of prescribing. 
Previously, a pragmatic, cluster randomised trial showed that 
the pharmacist-led PINCER intervention, on which SMASH is 
based, is an effective method for reducing medication errors 
in general practice. Recently, a cluster-randomized, stepped-
wedge trial in 33 general practices in Tayside, Scotland, 
showed that a complex intervention combining professional 
education, informatics and financial incentives reduced the 
rate of high-risk prescribing of antiplatelet medications and 
NSAIDs.37
As noted by Ammenwerth et al.,38 any installation of health 
IT for medication safety must be based on an overarching 
medication safety strategy that is underwritten by the institu-
tion where the installation takes place. In line with this rec-
ommendation, we have worked in close collaboration with 
the local CCG in the development and roll-out of the SMASH 
dashboard, and they were instrumental in the roll-out becom-
ing a success by resourcing pharmacist time and developing 
the strategy to recruit general practices and pharmacists.
The dashboard updates each night providing the users 
with up-to-date information whenever they choose to access 
it. Previous studies have shown that there is evidence that 
this immediate access to information may improve patient 
outcomes.20,39 SMASH conforms to most of the 15 sugges-
tions for practice feedback interventions laid out by Brehaut 
et al.,39 such as: providing feedback in multiple ways (tables 
and graphs); providing individual rather than general data 
and recommending actions that are under the user’s control. 
We have developed computable representations of evi-
dence-based prescribing safety indicators, but it is challeng-
ing to determine whether a patient is currently prescribed a 
medication due to the absence of drug termination codes. 
The simple approach that looks for any prescriptions in the 
last 3 months is overly sensitive and flags up patients who 
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Figure 6 System screenshot: chart showing the proportion of eligible patients who are 
affected for each practice within the CCG
Figure 5 System screenshot: detailed information and evidence about the asthma and beta blocker indicator
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their safe care is important40 and the ability for patients to dis-
cover when they are ‘flagged up’ by safety systems such as 
this will start to change the interactions between the patient 
and provider, and opens up several interesting avenues for 
future research.
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have since stopped their medication. It also has the problem 
that there may be nothing actionable the GP or pharmacist 
can do to remove the patient from the dashboard – they must 
instead wait until their most recent medication is before the 
window of inspection. This has the potential to discourage 
usage of the dashboard and could also lead to extra work 
as users repeatedly review a patient’s record. The algo-
rithmic approach is more promising, but requires additional 
pre-processing work to map drug codes to ingredients and 
strengths.
One limitation is that we have built a system external to 
the GPs standard EHR systems and so users are required to 
view patient lists within SMASH, before looking the patients 
up in a separate system. A more integrated approach would 
be easier for the end user, though given the high levels of 
usage that we have observed, it is a problem that the users 
are perhaps willing to overlook. Future versions of GP sys-
tems should consider incorporating safety indicators.
Over the coming years, we will: improve the existing dash-
board based on feedback from the trial; deploy more indi-
cators; roll out the system across Greater Manchester and 
working with industry partners and explore ways of allowing 
patients to interact with the system. The role of patients in 
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Table 1 Descriptions of the 13 indicators deployed in the current dashboard and the clinical aim of each
# Description Clinical aim
1 Prescription of an oral NSAID without co-prescription of an ulcer-
healing drug in a patient aged ≥65 years.
Prevent gastrointestinal bleeding.
2 Prescription of an oral NSAID without co-prescription of an ulcer-
healing drug to a patient with a history of peptic ulceration.
Prevent gastrointestinal bleeding.
3 Prescription of an antiplatelet drug without co-prescription of an 
ulcer-healing drug to a patient with a history of peptic ulceration.
Prevent gastrointestinal bleeding.
4 Prescription of warfarin or NOAC in combination with an oral 
NSAID.
Prevent gastrointestinal bleeding.
5 Prescription of warfarin or NOAC in combination with and an 
antiplatelet drug without co-prescription of an ulcer-healing drug.
Prevent gastrointestinal bleeding.
6 Prescription of aspirin in combination with another antiplatelet drug 
without co-prescription of an ulcer-healing drug.
Prevent gastrointestinal bleeding.
7 Prescription of a non-selective beta-blocker to a patient with 
asthma.
Prevent acute asthma exacerbation.
8 Prescription of a long-acting beta-2 agonist inhaler (excluding 
combination products with inhaled corticosteroid) to a patient with 
asthma who is not also prescribed an inhaled corticosteroid.
Prevent acute asthma exacerbation.
9 Prescription of an oral NSAID to a patient with heart failure. Prevent thrombotic risk.
10 Prescription of an oral NSAID to a patient with chronic renal failure 
(eGFR < 45) already prescribed an ACE inhibitor/ARB and loop 
diuretic
Prevent acute kidney injury.
11 Prescription of an oral NSAID to a patient with chronic renal failure 
(eGFR <45)
Prevent acute kidney injury.
12 Prescription of Methotrexate without both a recent full blood count 
and a recent liver function test.
Prevent liver damage (liver function test) and the 
development of neutropaenia (full blood count).
13 Prescription of Amiodarone without a thyroid function test. Prevent hypo and hyperthyroidism.
NOAC = novel anticoagulants such as apixaban, dabigatran or rivaroxaban. Antiplatelet drugs are aspirin, clopidogrel, prasugrel and ticagrelor. Peptic 
ulceration includes upper gastrointestinal bleeds, but does not include peptic ulcer surgery, gastritis, duodenitis or oesophageal varices. Ulcer-healing drugs 
include the PPIs and H2-antagonist – it does not include Misoprostol, Sucralfate or Bismuth.
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